side effects of glp 1 tirzepatide Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role | Cardiovascular Diabetology Tirzepatide vs Semaglutide: Which Weight

You still have to capitalize on those conditions

Hoping it picks back up soon cause this is getting expensive Michelle A., 36, Halifax NS Neither concern is valid

While still above 90%, it falls meaningfully short of the 99%+ claim on the label

Semaglutide (Ozempic and Wegovy) resulted in a 14.9% reduction in body weight in clinical trials, while tirzepatide (Mounjaro and Zepbound) led to a 20.9% body weight reduction

In addition to Wegovy, there are other brand-name GLP-1 medications that were developed specifically for weight loss, most notably Zepbound and Saxenda

Cheeks that dont look quite as lifted as before